Tracking Compounded Semaglutide: Extra Care, Extra Notes

Plenty of people taking semaglutide today have never held a brand-name pen. Shortages, cost and telehealth prescribing have put compounded semaglutide, dispensed as a small vial and a bag of syringes, into a lot of refrigerators. Whatever the route that got it there, one thing is objectively true: compounded medication shifts work from the manufacturer to you, and some of that work is record-keeping.

A brand pen encodes the dose in hardware. You dial a click-stop, the pen delivers a fixed amount, and the biggest tracking question is what day it happened. A vial encodes nothing. The dose lives in the interaction between a concentration printed on a label and a line on a syringe barrel, and both can change from one fill to the next. That is why tracking compounded semaglutide well takes a few extra notes, and why those notes matter more, not less.

What "compounded" actually means

Compounded semaglutide is prepared by a compounding pharmacy rather than by the original manufacturer. Compounding itself is a long-standing, legitimate part of pharmacy practice, but compounded drug products are not FDA-approved products: they do not go through the same review, and oversight varies with the type of pharmacy and the state it operates in. Regulatory conditions around compounded GLP-1s have also shifted over time, particularly as brand shortages have come and gone.

None of that is a verdict in either direction. It is simply the context that explains this article’s theme: with a compounded product, more of the consistency depends on the specific pharmacy, the specific batch, and the specific person drawing up the dose. Your log is the one thread that runs through all of it.

Units versus milligrams: the conversion that rules everything

Compounded semaglutide is usually drawn up with insulin syringes, whose markings are in units. A unit is a measure of volume here: on a standard U-100 syringe, 100 units equal 1 mL. How much semaglutide is actually in those units depends entirely on the vial’s concentration, which the pharmacy chooses and prints on the label as milligrams per milliliter.

This is the single most important thing to understand: the same number of units can mean a different dose from a different vial. At a concentration of 1 mg/mL, 25 units contain 0.25 mg. At 2.5 mg/mL, those same 25 units contain 0.625 mg. Switch pharmacies, or receive a new batch at a new concentration, and the syringe markings silently change meaning. Your prescriber’s instructions should always specify how many units to draw for your current vial; if a new label shows a different concentration and the units instruction has not changed, that is a phone call to the pharmacy before the next injection, not a judgment call at the kitchen counter.

For tracking, the practical rule is to record three things, not one: the units you drew, the concentration on the vial, and the resulting dose in milligrams. Milligrams are the stable language, the one your prescriber thinks in and the one that maps onto the familiar semaglutide ladder from the brand labels. Units are the operational language of the syringe. A log that captures both, plus the concentration that links them, can never be silently invalidated by a pharmacy change.

Two small habits make this near-foolproof. First, copy each new vial’s label details into your log the day it arrives, before the first draw, while comparing it against the old vial is still easy. Second, confirm the syringes themselves match what your instructions assume. Insulin syringes come in several barrel sizes (0.3, 0.5 and 1 mL are common), and while units mean the same volume on any U-100 syringe, the spacing and labeling of the lines differ between sizes, which is exactly where misreads happen. If a refill changes your syringe style along with your vial, slow down and re-check the draw with fresh eyes.

Why meticulous logging matters more here

With a brand pen, a sparse log is mostly an inconvenience. With a compounded vial, gaps in the record remove the only documentation of what you actually took. A few situations where the extra notes earn their keep:

• A new vial arrives at a different concentration. Your log shows exactly when the change happened and what the dose was on each side of it.
• Side effects shift after a refill. If nausea returns or fades right where the log shows a new batch beginning, you and your prescriber have something concrete to discuss instead of a hunch.
• Your prescriber adjusts the plan. A record in milligrams makes your history legible even if the units and concentrations changed twice along the way.
• You switch to a brand product, or back. Continuity of the milligram record means the transition does not orphan months of history.

Alongside dose details, it is worth noting the pharmacy name and the beyond-use date from each vial’s label. Compounded preparations carry beyond-use dates rather than long shelf lives, and storage still follows the familiar rules: refrigerated per the label, never frozen, and checked with the pharmacy if anything about the vial looks off.

GLP 1 Tracker AppFree on the App Store. Compounded semaglutide and tirzepatide presets, custom doses, notes on every entry, all stored on your phone. Get the app

The injection itself has not changed

Everything else about a semaglutide injection carries over from the brand world. It is subcutaneous, into the abdomen (keeping roughly two inches clear of the navel), the front of the thighs, or the back of the upper arms. Sites should rotate, both across regions and between spots within a region, to prevent irritation and the lumpy tissue changes that come from favoring one patch of skin; never inject into skin that is bruised, scarred or tender. Recording the site with each dose makes rotation automatic instead of a memory game, and our site rotation guide lays out simple systems that work.

The molecule is the same too, which means the pharmacology you may have read about brand semaglutide still applies: a half-life of about a week, gradual accumulation toward a steady state over roughly a month, and dips rather than cliffs when a dose lands late. Our guide to the semaglutide half-life covers that rhythm, and the weekly tracking habits in our Ozempic tracker guide translate directly, with the vial-specific notes above layered on top.

A weekly routine for vial users

Condensed into a checklist, a solid compounded-semaglutide routine looks like this:

• Before drawing up: confirm the concentration on this vial matches the one your units instruction was written for.
• Draw the prescribed units, double-checking the syringe line.
• Inject at the next site in your rotation.
• Log immediately: dose in milligrams, units drawn, concentration, site, and the vial’s pharmacy if it changed.
• During titration weeks, add a short side effect note with severity; patterns around dose steps are exactly what your prescriber will ask about.

It reads like a lot; in practice it is under a minute, and most weeks nothing changes except the site. The point is that on the weeks something does change, the change gets written down.

The takeaway

Compounded semaglutide asks you to be your own quality record. Not because anything is necessarily wrong with what is in the vial, but because the vial cannot speak for itself the way a factory pen does. Log the units, the concentration and the milligrams together, note the pharmacy and the dates, keep the site rotation honest, and write down how each step treats you. That record protects the one thing every version of this medication depends on: knowing exactly what you took, and when.